irbesartan and hydrochlorothiazide

Generic: irbesartan and hydrochlorothiazide

Labeler: alembic pharmaceuticals limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name irbesartan and hydrochlorothiazide
Generic Name irbesartan and hydrochlorothiazide
Labeler alembic pharmaceuticals limited
Dosage Form TABLET
Routes
ORAL
Active Ingredients

hydrochlorothiazide 12.5 mg/1, irbesartan 300 mg/1

Manufacturer
Alembic Pharmaceuticals Limited

Identifiers & Regulatory

Product NDC 46708-443
Product ID 46708-443_bbfa2906-f126-40a2-a5c4-8cbe19388fcc
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA091370
Listing Expiration 2026-12-31
Marketing Start 2016-05-23

Pharmacologic Class

Established (EPC)
thiazide diuretic [epc] angiotensin 2 receptor blocker [epc]
Mechanism of Action
angiotensin 2 receptor antagonists [moa]
Chemical Structure
thiazides [cs]
Physiologic Effect
increased diuresis [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 46708443
Hyphenated Format 46708-443

Supplemental Identifiers

RxCUI
310792 310793 485471
UPC
0346708442309 0346708444303 0346708443306
UNII
0J48LPH2TH J0E2756Z7N
NUI
N0000175359 N0000175419 M0471776 N0000000070 N0000175561

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name irbesartan and hydrochlorothiazide (source: ndc)
Generic Name irbesartan and hydrochlorothiazide (source: ndc)
Application Number ANDA091370 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 12.5 mg/1
  • 300 mg/1
source: ndc
Packaging
  • 10 TABLET in 1 BLISTER PACK (46708-443-10)
  • 30 TABLET in 1 BOTTLE (46708-443-30)
  • 90 TABLET in 1 BOTTLE (46708-443-90)
  • 1000 TABLET in 1 BOTTLE (46708-443-91)
source: ndc

Packages (4)

Ingredients (2)

hydrochlorothiazide (12.5 mg/1) irbesartan (300 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "bbfa2906-f126-40a2-a5c4-8cbe19388fcc", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776", "N0000000070", "N0000175561"], "upc": ["0346708442309", "0346708444303", "0346708443306"], "unii": ["0J48LPH2TH", "J0E2756Z7N"], "rxcui": ["310792", "310793", "485471"], "spl_set_id": ["9492a1cd-c012-4b43-931d-235220065e1e"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]", "Angiotensin 2 Receptor Blocker [EPC]"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "manufacturer_name": ["Alembic Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 TABLET in 1 BLISTER PACK (46708-443-10)", "package_ndc": "46708-443-10", "marketing_start_date": "20160523"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (46708-443-30)", "package_ndc": "46708-443-30", "marketing_start_date": "20160523"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (46708-443-90)", "package_ndc": "46708-443-90", "marketing_start_date": "20160523"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (46708-443-91)", "package_ndc": "46708-443-91", "marketing_start_date": "20160523"}], "brand_name": "Irbesartan and Hydrochlorothiazide", "product_id": "46708-443_bbfa2906-f126-40a2-a5c4-8cbe19388fcc", "dosage_form": "TABLET", "pharm_class": ["Angiotensin 2 Receptor Antagonists [MoA]", "Angiotensin 2 Receptor Blocker [EPC]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "46708-443", "generic_name": "Irbesartan and Hydrochlorothiazide", "labeler_name": "Alembic Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Irbesartan and Hydrochlorothiazide", "active_ingredients": [{"name": "HYDROCHLOROTHIAZIDE", "strength": "12.5 mg/1"}, {"name": "IRBESARTAN", "strength": "300 mg/1"}], "application_number": "ANDA091370", "marketing_category": "ANDA", "marketing_start_date": "20160523", "listing_expiration_date": "20261231"}